List of bibliographic references
Number of relevant bibliographic references: 16.
| Ident. | Authors (with country if any) | Title |
|---|
| 000034 (2014) |
Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien Carnicella | Pramipexole reverses Parkinson's disease-related motivational deficits in rats. |
| 000040 (2014) |
Nagaraj D. Halemani [France] | Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation? |
| 000043 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000045 (2014) |
Olivier Flabeau [France] ; Wassilios G. Meissner ; Annaig Ozier ; Patrick Berger ; François Tison ; Pierre-Olivier Fernagut | Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. |
| 000060 (2013) |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
| 000105 (2012) |
Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni] | Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies |
| 000138 (2011) |
Benjamin Dehay [France] ; Erwan Bezard | New animal models of Parkinson's disease. |
| 000181 (2011) |
Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A tale on animal models of Parkinson's disease |
| 000255 (2009) |
Carine Karachi [France] ; David Grabli [France] ; Nicolas Baup [France] ; Stéphanie Mounayar [France] ; Dominique Tandé [France] ; Chantal François [France] ; Etienne C. Hirsch [France] | Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys |
| 000321 (2007) |
Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 000370 (2006) |
Ruth H. Walker [États-Unis] ; Adrian Danek [Allemagne] ; Carol Dobson-Stone [Australie] ; Renzo Guerrini [Italie] ; Hans H. Jung [Suisse] ; Anne-Louise Lafontaine [Canada] ; Luca Rampoldi [Italie] ; François Tison [France] ; Eva Andermann [Canada] | Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes |
| 000383 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 000475 (2002) |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 000513 (2001) |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice |
| 000519 (2000) |
Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France] | Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration |
| 000583 (1997) |
Mohamed Jaber [États-Unis, France] ; Sara Jones [États-Unis] ; Bruno Giros [États-Unis] ; Caron [États-Unis] | The dopamine transporter: A crucial component regulating dopamine transmission |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Disease Models, Animal"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i \
-Sk "Disease Models, Animal" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= KwdEn.i
|clé= Disease Models, Animal
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
